Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C

Am J Gastroenterol. 2000 Dec;95(12):3670-3. doi: 10.1111/j.1572-0241.2000.03413.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Drug Therapy, Combination
  • Female
  • Hepatitis C, Chronic / blood*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Interferon-gamma / immunology*
  • Interleukin-2 / immunology*
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • T-Lymphocyte Subsets / immunology*
  • Time Factors

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukin-2
  • Recombinant Proteins
  • Ribavirin
  • Interferon-gamma